Nauman Rahim Khan | Pharmaceutical Sciences | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Nauman Rahim Khan | Pharmaceutical Sciences | Best Researcher Award

Associate Professor, Kohat University of Science and Technology, Pakistan

Dr. Nauman Rahim Khan is an accomplished academician, researcher, and pharmaceutical scientist. With a B.Pharm, M.Phil, and PhD in Pharmaceutics from UiTM, Malaysia, he has devoted himself to advancing pharmaceutical sciences, specializing in transdermal drug delivery systems, wound healing, and nanotechnology. Dr. Khan holds the position of Associate Professor at the Department of Pharmacy, Kohat University of Science and Technology. His professional career spans over a decade, during which he has made significant contributions to academia and research. He has supervised numerous postgraduate students and has collaborated internationally with institutions such as Najran University, KSA, and UiTM, Malaysia. Dr. Khan is known for his passion for innovation in drug delivery systems and his commitment to improving pharmaceutical practices. His expertise and dedication have earned him numerous awards, including the prestigious Gold Medal at the Malaysia Technology Expo 2017.

Profile

Education

Dr. Nauman Rahim Khan earned his PhD in Pharmaceutics from UiTM, Malaysia (2013-2016), where his research focused on skin delivery using novel techniques like microwave-assisted drug permeation enhancement. Prior to his PhD, he completed an M.Phil in Pharmaceutics from Gomal University D.I. Khan in 2011 with a CGPA of 3.46, and a B.Pharm degree in 2006, securing first position in his class. His academic journey is highlighted by excellence in research and contributions to the field of pharmaceutical sciences. Dr. Khan also undertook further language training, completing a 6-week French language course at NUML Peshawar in 2012. Throughout his career, Dr. Khan has demonstrated a profound commitment to advancing his knowledge and applying it in practical pharmaceutical applications.

Experience

Dr. Nauman Rahim Khan has a distinguished teaching career spanning over 15 years. He currently serves as an Associate Professor at the Department of Pharmacy, Kohat University of Science and Technology. Prior to this role, he was a Lecturer in Pharmaceutics at Gomal University D.I. Khan from 2008 to 2021. In addition to his academic responsibilities, Dr. Khan has held several key administrative positions, including Deputy Director of the Quality Enhancement Cell and Program Director for the HEC β€œEhsas Undergraduate Scholarship Project.” He has also been a member of various university committees, including the Pharmacy Council of Pakistan. Dr. Khan has supervised numerous M.Phil and PhD students and continues to be an active mentor in the academic community. His experience extends beyond teaching, as he has been involved in national and international research collaborations, further enhancing his role as a researcher and educator.

Awards and Honors

Dr. Nauman Rahim Khan has received multiple prestigious awards throughout his career. Notably, he was honored with the Gold Medal at the Malaysia Technology Expo 2017 for his innovative work on microwave-assisted skin drug delivery. He also received the TEFARCO Innova-PharmaTech Scientists Award in 2016 at PharmaBioAsia. In recognition of his academic excellence, Dr. Khan was awarded the University Gold Medal from Gomal University for securing the first position in his B.Pharm program (2002-2006). His remarkable achievements include winning the “Presidential Scholarship Award” from the Ministry of Health, Islamabad, Pakistan, and being selected for the “Interprovincial Exchange of Students Delegations” program. Additionally, Dr. Khan’s overseas PhD scholarship by the Higher Education Commission of Pakistan further reflects his outstanding academic prowess. His continued success has earned him recognition in both national and international forums.

Research Focus

Dr. Nauman Rahim Khan’s research primarily focuses on advanced drug delivery systems, with particular interest in skin drug delivery technologies and wound healing. His work includes developing polymeric nanoparticles, nano-ethosomes, and transdermal drug delivery systems for enhanced therapeutic efficacy. Dr. Khan’s research on microwave-assisted drug delivery systems aims to improve the skin permeation of various pharmaceuticals, particularly in the treatment of burns and diabetic wounds. He also explores the use of nanocomposites for wound healing, including burn and diabetic wounds, and is actively involved in the development of novel drug carriers. Additionally, his research delves into the application of 3D printing in pharmaceutical sciences, allowing for customized drug formulations. Dr. Khan is committed to translating his research into practical solutions for improved healthcare, particularly in developing novel formulations for drug delivery and tissue regeneration.

Publication Top Notes

  1. “Nanocarriers and their Actions to Improve Skin Permeability and Transdermal Drug Delivery” πŸ“¦πŸ’Š
  2. “Microwave-aided skin drug penetration and retention of 5-fluorouracil-loaded ethosomes” πŸŒ‘οΈπŸ’‰
  3. “Formulation and in vitro evaluation of clotrimazole gel containing almond oil and tween 80 as penetration enhancer for topical application” 🧴🌰
  4. “5-Fluorouracil ethosomes–skin deposition and melanoma permeation synergism with microwave” πŸ”¬πŸ§΄
  5. “Physico-chemical based mechanistic insight into surfactant modulated sodium Carboxymethylcellulose film for skin tissue regeneration applications” πŸ’‘πŸ§ͺ
  6. “3D printing technology: A new approach for the fabrication of personalized and customized pharmaceuticals” πŸ–¨οΈπŸ’Š
  7. “Effect of olive oil on transdermal penetration of flurbiprofen from topical gel as enhancer.” πŸˆπŸ’§
  8. “Formulation and evaluation of microwave-modified chitosan-curcumin nanoparticlesβ€”a promising nanomaterials platform for skin tissue regeneration applications following burn wounds” 🌿πŸ”₯

 

 

 

Stuart Maudsley | Receptor Pharmacology | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Stuart Maudsley | Receptor Pharmacology | Best Researcher Award

Senior Fellow/Professor, H. Lee Moffitt Cancer Center, United States

Dr. Stuart Russell Maudsley is a renowned pharmacologist with a distinguished career in receptor biology, specializing in therapeutic precision medicines targeting GPCRs (G-Protein Coupled Receptors). He is currently the Principal Investigator at the Maudsley Lab and a Senior Member at Moffitt Cancer Center. Dr. Maudsley is also a co-founder of HeptOME, focusing on aging-related diseases and metabolic dysfunction. With over two decades of research experience, he has held prominent roles including scientific advisor to the Belgian Superior Health Council, and various leadership roles at Johns Hopkins, the NIH, and VIB. His groundbreaking work includes receptor pharmacology and molecular biology studies aimed at advancing novel treatments for complex human disorders, particularly cancer and neurodegenerative diseases. His career has been recognized globally, earning numerous awards and honors for his contributions to molecular pharmacology.

Profile

Education

Dr. Stuart Russell Maudsley obtained his PhD in Pharmacology from the University of Leeds, UK, where he was awarded the Ackroyd, Brotherton & Brown Scholarship. His doctoral research focused on electrophysiological and molecular biological studies of Tachykinin receptors, marking the beginning of his illustrious career in receptor pharmacology. Prior to his PhD, Dr. Maudsley earned a First-Class B.Sc. in Pharmacology from the same institution. During his academic tenure, he engaged in advanced studies of ion channel electrophysiology and the pharmacology of the central nervous system, topics that have significantly shaped his subsequent research endeavors. His educational foundation laid the groundwork for his future contributions in both academia and the pharmaceutical industry, particularly in the development of novel therapeutic strategies for neurodegenerative diseases, cancer, and metabolic disorders.

Experience

Dr. Stuart Russell Maudsley boasts an extensive career with leadership roles across academia, industry, and government. He is the Principal Investigator at the Maudsley Lab at Moffitt Cancer Center and the co-founder of HeptOME, where he focuses on receptor-targeted therapies for aging-related metabolic diseases. Throughout his career, Dr. Maudsley has held various significant positions, including Adjunct Director at VIB, Vice-Chair at the University of Antwerp’s Department of Biomedical Science, and Principal Investigator at the NIH. He has contributed to numerous international projects, including his work as a Special Science Advisor to the Belgian Superior Health Council. Dr. Maudsley has also led scientific teams at Johnson & Johnson, the U.S. Department of Defense, and the NIH, where he made crucial contributions to drug development and the understanding of receptor pharmacology. His leadership and expertise have resulted in groundbreaking advancements in the pharmacology and therapeutics of complex diseases.

Awards and Honors

Dr. Stuart Russell Maudsley has received numerous prestigious awards and honors throughout his career. Notable recognitions include the 2021 UAntwerpen Seal of Excellence Grant, 2020 Johnson & Johnson Research Grant, and the 2019 FWO Doctoral Research Grant. He has also been honored with the FWO Senior Research Fellows Grant and the UAntwerpen-IOF Industrial Collaboration Research Grant in 2019. His work in molecular pharmacology and receptor biology has led to the receipt of multiple awards from both European and American institutions, including the National Institutes of Health On-the-Spot Award (2011-2013). Dr. Maudsley’s groundbreaking research on neurodegenerative diseases, aging, and metabolic dysfunction has earned him widespread recognition in the scientific community. His scientific excellence and contributions to pharmacology, drug discovery, and biotechnology continue to inspire advancements in the treatment of complex human disorders.

Research Focus

Dr. Stuart Russell Maudsley’s research primarily focuses on receptor pharmacology, with a special emphasis on G-Protein Coupled Receptors (GPCRs) and their role in human disease. His work seeks to identify and develop precision GPCR-targeted therapies for cancer, neurodegenerative disorders, and metabolic diseases such as obesity and aging-related conditions. Through his leadership in both academic labs and the biotech industry, Dr. Maudsley investigates novel biotechnological platforms, including both wet and dry biomedical technologies. He aims to create multidimensional precision medicines that can more effectively treat complex disorders, particularly those related to aging. His current research in the Maudsley Lab centers on the molecular mechanisms that underlie aging and neurodegenerative diseases, as well as the identification of potential therapeutic agents. By exploring the intricate signaling pathways of GPCRs, Dr. Maudsley is paving the way for the development of innovative treatments for diseases that currently lack effective therapies.

Publications Top Notes

  • Ξ²-Arrestin-dependent formation of Ξ²2 adrenergic receptor-Src protein kinase complexes – Science (1999) πŸ§¬πŸ“š
  • BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders – Trends in Neurosciences (2004) 🧠
  • The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women – International Journal of Obesity (2011) πŸπŸƒβ€β™€οΈ
  • Gonadotropin-releasing hormone receptors – Endocrine Reviews (2004) πŸ’ŠπŸ”¬
  • Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma – Free Radical Biology and Medicine (2007) πŸ₯
  • Caloric restriction and intermittent fasting: two potential diets for successful brain aging – Ageing Research Reviews (2006) 🧠
  • The Ξ²2-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor – Journal of Biological Chemistry (2000) πŸ§¬πŸ”¬